1WHO/ISH Hypertension Guidelines Committee. 1999 World Health Organization - International society of hypertension guidelines for the management of hypertension[J]. J Hypertens, 1999, 17:151 - 185.
2Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure [ J ].Arch Intren Med, 1997, 157 (21): 2 413 -2 444.
3Pitt B, Segal R, Martintz F, et al. Randomized trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE) [J]. Lancet, 1997, 349:744 -752.
4WHO/ISH Hypertension Guidelines Committee.1999World Health Organization-international society of hyper-tension guidelines for the management of hypertension[J].J Hypertens,1999,17:151-185.
6Shobha JC,Kumar TR,Raju BS,et al.Evaluation of efficacy and safety of losartan potassium in the treatment of mild to moderate hypertension as compared to enalapril maleate[J].J Assoc Physicians India,2000,48:497-500.
7Blazer EL,Nicolay K,Koomans HA,et al.Losartan versus enalapril on cerebral edema and proteinueia in strokeprone hypertensive rats[J].Am J Hypertension,2001,14:54-61.
8Johannes FE.Valsartan and the kidney,present and future[J].J Cardiovas Pharmacol,1999,33 (suppll):37-40.
9S See Angiotensin Ⅱ receptor blockers for the treatment of hypertension[J].Expert Opin Pharmacother,2001,2(11):1795.
